MYC-Induced miR-203b-3p and miR-203a-3p Control Bcl-xL Expression and Paclitaxel Sensitivity in Tumor Cells

Area of Science:

• Oncology
• Molecular Biology
• Cancer Therapeutics

Background:

• Taxanes are crucial chemotherapeutics for solid tumors, but patient responses vary significantly.
• The molecular mechanisms driving taxane sensitivity and cancer cell death remain incompletely understood.
• Signaling pathways that promote taxane-induced cell death are poorly characterized.

Purpose of the Study:

• To elucidate novel molecular determinants of taxane sensitivity.
• To identify signaling pathways that regulate cancer cell death in response to paclitaxel.
• To investigate the role of c-Myc and specific microRNAs in taxane response.

Main Methods:

• Investigated the c-Myc-mediated signaling pathway involving miR-203b-3p and miR-203a-3p.
• Utilized in vitro experiments to assess the effect of miR-203b-3p on Bcl-xL expression and cancer cell fate.
• Analyzed patient tumor data to correlate MYC and microRNA expression with therapy response and survival.

Main Results:

• c-Myc enhances paclitaxel sensitivity by upregulating miR-203b-3p and miR-203a-3p.
• miR-203b-3p directly targets Bcl-xL mRNA, decreasing its expression and promoting cell death in paclitaxel-treated cancer cells.
• High expression of miR-203b-3p and MYC in breast tumors correlated with better therapeutic outcomes and patient survival.

Conclusions:

• A novel c-Myc/miR-203b-3p/Bcl-xL pathway regulates paclitaxel sensitivity.
• Overexpression of miR-203b-3p shifts paclitaxel-treated cancer cells towards death rather than survival.
• These findings suggest potential for patient stratification in taxane-based therapies.